Browse by author
Lookup NU author(s): Marcus Drake
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Purpose: Nocturia is a common condition often attributed in aging men to benign prostatic enlargement. Older adults are prone to nocturnal sleep disturbance, of which disturbed circadian rhythm may be a component since it improves with nighttime administration of melatonin. This study was designed to investigate melatonin as a potential treatment for nocturia associated with bladder outflow obstruction in older men. Materials and Methods: A total of 20 men with urodynamically confirmed bladder outflow obstruction and nocturia were entered into a randomized, double blind, placebo controlled crossover study assessing the effect of 2 mg controlled release melatonin at night on nocturia. Symptoms were assessed at baseline and after each 4-week treatment period using a frequency volume chart, the International Prostate Symptom Score and symptom problem index. Maximum urinary flow rate and post-void residual urine volume were also assessed. Results: Baseline frequency of nocturia was 3.1 episodes per night. There were 7 men (35%) with detrusor overactivity and 10 (50%) had nocturnal polyuria. Melatonin and placebo caused a decrease in nocturia of 0.32 and 0.05 episodes per night (p = 0.07) and a decrease in the nocturia bother score of 0.51 and 0.05, respectively (p = 0.008). Nocturia responder rates (a reduction from baseline of at least -0.5 episodes per night) differed between the active medication and placebo groups (p = 0.04). Daytime urinary frequency, International Prostate Symptom Score, relative nocturnal urine volume, maximum urinary flow rate and post-void residual were unaffected by melatonin treatment. Conclusions: Melatonin treatment is associated with a significant nocturia response rate, improvement in nocturia related bother and a good adverse effect profile. However, it is uncertain whether the observed changes in this study are clinically significant.
Author(s): Drake MJ, Mills IW, Noble JG
Publication type: Article
Publication status: Published
Journal: Journal of Urology
Year: 2004
Volume: 171
Issue: 3
Pages: 1199-1202
Print publication date: 01/03/2004
ISSN (print): 0022-5347
ISSN (electronic): 1527-3792
Publisher: Elsevier
URL: http://dx.doi.org/10.1097/01.ju.0000110442.47593.ea
DOI: 10.1097/01.ju.0000110442.47593.ea
PubMed id: 14767300
Altmetrics provided by Altmetric
